Characteristics | Descriptive statistic | Total sample n = 149 | NAC n = 76 | Placebo n = 7 3 | Test statistic | Value | df | P |
---|---|---|---|---|---|---|---|---|
Symptoms | Â | Â | Â | Â | Â | Â | Â | Â |
   YMRSa | M(SD) | 1.5 (2.1) | 1.7 (2.4) | 1.4 (1.9) | t-test | 0.37 | 130 | .716 |
   MADRSb | M(SD) | 12.6 (9.8) | 13.1 (9.72) | 12.2 (9.9) | t-test | 0.47 | 130 | .638 |
   BDRSa | M(SD) | 10.7 (9.1) | 11.3 (8.5) | 10.1 (9.7) | t-test | 1.20 | 130 | .233 |
   CGI-BP Severity |  |  |  |  |  |  |  |  |
Depressiona | M(SD) | 2.8 (1.2) | 2.9 (1.2) | 2.8 (1.2) | t-test | 0.49 | 129 | .625 |
Maniaa | M(SD) | 1.3 (0.7) | 1.4 (0.7) | 1.3 (0.6) | t-test | 0.17 | 129 | .620 |
Overalla | M(SD) | 2.9 (1.2) | 2.9 (1.2) | 2.8 (1.2) | t-test | 0.29 | 128 | .771 |
   CGI-BP Improvement |  |  |  |  |  |  |  |  |
   Depressiona | M(SD) | 2.5 (1.2) | 2.5 (1.1) | 2.6 (1.3) | t-test | -0.17 | 129 | .864 |
   Maniaa | M(SD) | 3.8 (0.7) | 3.8 (0.7) | 3.9 (0.7) | t-test | -0.63 | 130 | .533 |
   Overalla | M(SD) | 2.6 (1.2) | 2.6 (1.2) | 2.7 (1.3) | t-test | -0.30 | 129 | .767 |
Functioning | Â | Â | Â | Â | Â | Â | Â | Â |
   GAF | M(SD) | 72.2 (13.7) | 71.1 (13.3) | 73.3 (14.1) | t-test | -0.92 | 129 | .360 |
   SOFAS | M(SD) | 72.1 (13.6) | 71.5 (13.0) | 72.6 (14.1) | t-test | -0.46 | 129 | .649 |
   LIFE-RIFT | M(SD) | 11.2 (3.8) | 11.5 (3.9) | 10.9 (3.8) | t-test | 0.83 | 130 | .410 |
   SLICE-LIFE | M(SD) | 16.5 (5.2) | 16.6 (5.3) | 16.5 (5.0) | t-test | 0.17 | 130 | .866 |
Q-LES-Q | M(SD) | 53.4 (10.8) | 52.5 (10.6) | 54.3 (11.0) | t-test | -0.98 | 130 | .325 |